Early Life Growth
The genetics group led by Stefan Johansson investigates how genetic variation affects human development, health, and disease. By combining population-level genomics, clinical data, and advanced computational methods, we seek to identify the biological mechanisms underlying diabetes and other complex disorders. Our research encompasses rare monogenic diseases, common complex traits, and early childhood development, with a particular focus on translating genetic findings into improved diagnostics, risk assessment, and precision medicine. Through close collaboration between researchers, clinicians, and international partners, our goal is to transform genomic data into knowledge that benefits patients and society.
About the research group
Key Research Areas
- Genetics related to diabetes and metabolic diseases
- Discovery of genes for rare diseases and functional genomics
- Growth, obesity, and cardiometabolic health across the lifespan
- Population genomics and biobank-based research
- Development of genomic methods for precision medicine and clinical implementation
Our work is builds on unique Norwegian health registries and biobanks, including the Norwegian Mother, Father, and Child Cohort Study (MoBa), as well as international collaboration to understand how genetic factors influence disease risk and health outcomes throughout life.
Tilganger
Vi har tilgang til flere unike norske og internasjonale undersøkelser og sykdomsspesifikke registre og biobanker, inkludert:
- Avon Longitudinal Study of Parent and Children (ALSPAC) (external link)
- Det norske MODY-registeret (external link)
- Det norske registeret for organ-spesifikke autoimmune sykdommer (ROAS) (external link)
- Helseundersøkelsene i Hordaland (HUSK) (external link)
- Mor og barn-undersøkelse (MoBa) kohorten (external link)
- Nasjonalt medisinsk kvalitetsregister for barne- og ungdomsdiabetes (Barnediabetesregisteret) (external link)
People
Group manager
Stefan Johansson Professor